Teva Pharmaceutical to invest $1 billion in IndiaIllustrative image – not actual.

Israel's Teva Pharmaceutical Industries is planning to invest over $1 billion (around Rs.4,000 crore) in India, by 2010, to acquire Indian drug companies and set up greenfield manufacturing facilities.

Of the total investment, around $250-$300 million will be utilised for manufacturing facilities and the rest to fund acquisitions in India.

The company has acquired over 100 acres of land near Gwalior, Madhya Pradesh, to set up active pharmaceutical ingredient (API) manufacturing facilities. It is also likely to integrate Regent Drugs, which it acquired from JK Industries in 2003, with its API business (TAPI).

← All latest storiesBack to top →